Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
about
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal healthAntibiotic treatment for the sexual partners of women with bacterial vaginosisIndividualized medicine and the microbiome in reproductive tractRationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal MicrobiomeAncient human microbiomesThe role of metagenomics in understanding the human microbiome in health and diseaseComparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the USMicrobiota composition of the koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease.Differences in vaginal microbiome in African American women versus women of European ancestry.Factors associated with participation and attrition in a longitudinal study of bacterial vaginosis in Australian women who have sex with women.Characteristics and quantities of HIV host cells in human genital tract secretionsImpact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon modelLongitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.The placenta harbors a unique microbiome.Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Longitudinal analysis reveals characteristically high proportions of bacterial vaginosis-associated bacteria and temporal variability of vaginal microbiota in northern pig-tailed macaques (Macaca leonina).Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosaCervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses.Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?Subclinical alteration of the cervical-vaginal microbiome in women with idiopathic infertility.Ovarian cycling and reproductive state shape the vaginal microbiota in wild baboonsEfficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis.Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells.In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp.The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report.Machine learning techniques accurately classify microbial communities by bacterial vaginosis characteristics.Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.Diversity of Cervical Microbiota in Asymptomatic Chlamydia trachomatis Genital Infection: A Pilot Study.Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.Does the vaginal microbiota play a role in the development of cervical cancer?Antibiotic treatment for the sexual partners of women with bacterial vaginosis.Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.Reproductive Microbiomes.Interplay between viruses and bacterial microbiota in cancer development.Clinical Validation of a Test for the Diagnosis of Vaginitis.A microbiome variable in the HIV-prevention equation.
P2860
Q21129223-C2DF679D-5A4E-40A7-B4F5-0FC4E91F3884Q24188259-4D213A26-11DD-497D-BC27-114B3FDBB75CQ26999090-6BC0D0E9-AD8F-4BF3-9C34-CF1329206A69Q28551446-A6F142C8-2064-4A61-A367-EA7CFB41A0B4Q28650805-AC086342-8203-46F1-8D35-154799BC232DQ31148228-CD0DA1BF-F565-4345-92FC-95E15D5A5B34Q33554048-7EE7FB8B-86C7-4CA7-96E7-C1D859C7666CQ33590354-6B9C4774-DC44-4710-BF8A-4B13C0A4D09DQ33899564-8B81E49E-9591-4D36-B802-7BCB4E1FCDE7Q34259440-F34DB51E-EB29-4AD7-8124-3CDCE09ABD10Q34550009-4F2C6D5D-2AA5-4EB9-A5CC-58F64F3E266CQ35000052-18ABB298-DFBC-447B-95F4-E8C6244779D2Q35050862-306D2FD8-40E5-4205-89CA-D2ABBA9DF702Q35077640-EF35EE0B-FE28-443A-A18D-FCC8DD673926Q35171983-71148CD3-AFE6-4053-9093-197A0E4DB291Q35415972-C55DDD55-AE06-4F41-A8A6-EC0FDFA030A3Q35689986-DA7CC684-4E27-4D03-A056-61456503E0E2Q35802094-C5AEF551-721A-4BC5-897C-A160C7308FC6Q35904651-FDA686E0-6F99-4AC7-A428-E6C369955429Q35943509-28D9E403-1A6B-47ED-81F5-3969E06D876CQ36211625-41FB7730-125B-4982-872B-509CB7A79833Q36232059-B322261E-538C-48B6-B1FC-254C6FB8F7F4Q36252346-EAC4BD0F-CF4D-41C9-860A-465EA4E4BF36Q36254631-CBD06AF7-706E-47D4-843E-AA269ECD1BC9Q36415171-E23ABDD3-654A-406B-B048-BE10B237C3A6Q36456903-F33C054D-149E-49D2-AE74-4CA63AE41E51Q37083889-F01F8EBD-B86E-499C-AF58-B649AB255A99Q37470529-A3C6E628-E360-4155-A115-1D68868C4A6DQ37501328-3C6CD84B-01B8-4D3C-AACC-324943991A21Q37549123-B480C213-4681-473A-80EF-F3285775FE75Q37721812-26E449E9-A169-467F-B458-41A94C4975BDQ37833704-D0945825-0FC6-48DA-9E60-6C90AC40CB25Q37838568-BC42901F-932D-4DC2-BF3C-2203D648AC0BQ38835933-09279994-E399-485A-8B9A-07B1DAA40958Q38970652-D7E0658F-3CB4-430F-9571-40C1D1112715Q39135146-5B854C42-FFB7-462A-AFA7-4619647DB027Q39189413-D139EA98-34E2-4CBD-A254-269AC1C92383Q39365350-51154560-C5F7-4D59-B5F5-405EA739A512Q40180169-6E3081A9-F618-481B-9D27-787EDF977E97Q40188578-ACD761EE-A2B6-46F4-A25D-500E85EF31EB
P2860
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@ast
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@en
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@nl
type
label
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@ast
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@en
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@nl
prefLabel
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@ast
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@en
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@nl
P2860
P921
P3181
P356
P1476
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
@en
P2093
Rebecca M. Brotman
P2860
P304
P3181
P356
10.1172/JCI57172
P407
P577
2011-12-01T00:00:00Z